Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation

Pauline Rimmelé, Olivier Kosmider, Patrick Mayeux, Françoise Moreau-Gachelin, Christel Guillouf

Blood (2006) 109 (7): 3007–3014.

https://doi.org/10.1182/blood-2006-03-006718

Published: 2006

Journal Articles

JAK2 V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis

Catherine Lacout, Didier F. Pisani, Micheline Tulliez, Françoise Moreau Gachelin, William Vainchenker, Jean-Luc Villeval

Blood (2006) 108 (5): 1652–1660.

https://doi.org/10.1182/blood-2006-02-002030

Published: 2006

Journal Articles

Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression

Erwan Le Scolan, Dimitri Pchejetski, Yoshiko Banno, Nicole Denis, Patrick Mayeux, William Vainchenker, Thierry Levade, Françoise Moreau-Gachelin

Blood (2005) 106 (5): 1808–1816.

https://doi.org/10.1182/blood-2004-12-4832

Published: 2005

Journal Articles

Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors

Stéphane Giraudier, Hédia Chagraoui, Emiko Komura, Stéphane Barnache, Benoit Blanchet, Jean Pierre LeCouedic, David F. Smith, Frédéric Larbret, Anne-Laure Taksin, Françoise Moreau-Gachelin, Nicole Casadevall, Michel Tulliez, Anne Hulin, Najet Debili, William Vainchenker

Blood (2002) 100 (8): 2932–2940.

https://doi.org/10.1182/blood-2002-02-0485

Published: 2002

Journal Articles

Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts

Stéphane Barnache, Patrick Mayeux, Bernard Payrastre, Françoise Moreau-Gachelin

Blood (2001) 98 (8): 2372–2381.

https://doi.org/10.1182/blood.V98.8.2372

Published: 2001

NARROW

Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation

JAK2 V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis

Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression

Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors

Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts

Email alerts

ASH Publications

American Society of Hematology

Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation

JAK2 V617F expression in murine hematopoietic cells leads to MPD mimicking human PV with secondary myelofibrosis

Overexpression of sphingosine kinase 1 is an oncogenic event in erythroleukemic progression

Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors

Alterations of the phosphoinositide 3-kinase and mitogen-activated protein kinase signaling pathways in the erythropoietin-independent Spi-1/PU.1 transgenic proerythroblasts

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only